Advances on improvements of oral absorption of enzymatic and polypeptide drugs

YANG Chao,YIN Zong-ning
DOI: https://doi.org/10.3321/j.issn:1003-3734.2006.12.003
2006-01-01
Abstract:An obvious downside of enzyme and polypeptide drugs is lower bioavailability (<1%).This paper presents the most advanced methods to improve the bioavailability of enzyme and polypeptide drugs by using enzyme inhibitors that can bind with Ca~(2+)and Zn~(2+)ions,the Zonula occlu- dens toxin protein,chemical substance carriers and the bioadhesion.The newer,more powerful technolo- gies were addressed,such as drug carriers with Sanguis draxonis and recombinant Saccharomyces cerevisiae, which offer exciting alternatives to improve the bioavailability of enzyme and polypeptide drug candidates.
What problem does this paper attempt to address?